[Proceedings: Erythrocyte 2,3-diphosphoglycerate during the development of myocardial infarct. Concerning 118 cases].
In four groups of patients with myocardial infarction the increase of 2.3-DPG concentration in erythrocyte was important when complications appeared during the evolution or when the patients died.
D001145:Arrhythmias, Cardiac / Q000378:metabolism; D004163:Diphosphoglyceric Acids / Q000097:blood*; D004912:Erythrocytes / Q000378:metabolism*; D006327:Heart Block / Q000378:metabolism; D006333:Heart Failure / Q000378:metabolism; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood*
D004163:Diphosphoglyceric Acids
Le 2,3-diphosphoglycérate érythrocytaire au cours de l'évolution de l'infarctus du myocarde